Clinical Trials Logo

Clinical Trial Summary

CREHA project is a study comparing steroid combined with cyclophosphamide versus steroid combined with rituximab in patients with acquired haemophilia. The study will test the hypothesis that steroid combined with cyclophosphamide is more effective than steroid plus rituximab for FVIII inhibitor eradication in acquired haemophilia.


Clinical Trial Description

CREHA project is a multicenter, randomized, controlled efficacity and safety study comparing steroid combined with cyclophosphamide versus steroid combined with rituximab in patients with acquired haemophilia. The study will test the hypothesis that steroid combined with cyclophosphamide is more effective than steroid plus rituximab for FVIII inhibitor eradication in acquired haemophilia ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01808911
Study type Interventional
Source University Hospital, Rouen
Contact Hervé LEVESQUE, MD, PhD
Phone (0)2 32 88 90 01
Email herve.levesque@chu-rouen.fr
Status Recruiting
Phase Phase 3
Start date May 2012
Completion date June 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01403740 - Turkish Acquired Haemophilia Registry N/A
Completed NCT00697320 - Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany N/A
Completed NCT00213473 - Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study N/A
Completed NCT01285089 - Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia N/A
Completed NCT01561417 - Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects Phase 1